Blood preparation market to witness lucrative growth prospects in U.S., Global industry revenue to surpass USD 64 billion by 2024
Rise in the worldwide demand for transfusion of blood due to increasing prevalence of blood related disorders has driven blood preparation market. The growing geriatric population base which is more susceptible to such disorders is one of the major factors driving the industry trends. According to Global Market Insights, Inc., “Blood preparation market is estimated to record a CAGR of over 4.4% over the period of 2016-2024 with a target revenue worth USD 64.38 billion by 2024.”Blood preparation industry is gaining considerable traction with the increasing government initiatives to spread awareness pertaining to blood disorders. For instance, CDC and NIH are actively launching awareness programs to combat the complications associated with thrombosis. Moreover, swift technological improvements in the testing equipment such as analyzers and centrifuges have aided in accurate and rapid diagnostics of the disorders.
China and India are expected to hold major revenue share of Asia Pacific. The rising healthcare expenditure, increasing blood-associated disorders and larger number of unmet medical needs are the attributing factors for the regional growth of blood preparation industry. Presence of a huge geriatric population base in China will further complement the regional growth.
U.S. Blood Preparation Market Size, by Product, 2012- 2024 (USD Million)
Pulmonary embolism and thrombocytosis are reported to be the leading causes of demise. In 2015, these two disorders together accounted for over 43% of total blood preparation market. Other applications of this industry include angina blood vessel complications and renal impairment.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/790
On the product front, the blood preparation industry is segmented into blood derivatives, components and whole blood. Blood components refer to products derived from platelet-rich plasma. This segment is likely to account for a considerable share in the coming years, owing to the increasing use of frozen plasma, platelet concentrate, leucocyte reduced RBCs, packed red cells and whole blood components. The whole blood product segment of the blood preparation market generated the highest revenue share, having accounted over 48% in 2015. Blood derivatives segment stood second by contributing 34% of the overall blood preparation industry share in 2015.
With reference to antithrombotic and anticoagulants type of drugs pipeline, blood preparation market is segmented into fibrinolytic, anticoagulants and platelet aggregation inhibitors. Rise in the incidences of thrombosis, and growing geriatric population has raised the demand for more efficacious drugs. Due to these reasons, anticoagulants led the overall blood preparation industry by collecting revenue over USD 17 billion in 2015. Government initiative regarding the awareness and prevention of thrombosis disorders is also likely to give a major push to the industry growth.
Developed and well equipped healthcare infrastructure in U.S. will propel the regional blood preparation market. U.S. also witnesses an increasing prevalence of thrombocytosis disorder which will contribute toward industry growth. U.S. market is estimated to surpass 25 billion by 2024, backed by several government initiative and high patient awareness levels.
The major industry participants are focusing on the research for efficient and cost-effective drugs to cure blood related disorders. To cope up with the ever-rising patient pool, the blood preparation market players are constantly engaged in developing innovative technologies. The companies are set to introduce rapid and easy handling instruments for the preparation of blood components. Key industry players include Pfizer, Sanofi Aventis, Leo Pharma, Bristol-Myers, Shandong East Chemical, GlaxoSmithKline, Celgene, Baxter Healthcare, and AstraZeneca.
Author Name : Ojaswita Kutepatil
Neurovascular devices market to record a substantial revenue via hospitals, coiling procedures to lead the process landscape over 2016-2024
Escalating prevalence of brain-related disorders coupled with the popularity of minimally invasive surgeries will spur neurovascular devices market. Touted to be one of the most lucrative growth avenues for medical device manufacturing corporations, this industry is slated to surpass a revenue of USD 2.3 billion by 2024, growing with a CAGR of 4.1% over 2016-2024. With the healthcare sector growing at a rapid pace across the globe, the demand for these medical devices has exponentially increased, thereby providing a positive impetus to global neurovascular devices market.
U.S. Neurovascular Devices Market Size, By Therapeutic application, 2012- 2024 (USD Million)
The demand for minimally invasive surgeries has perpetually increased worldwide, propelled by the reduced hospital stays, favorable medical insurance and reimbursement policies, and the convenience and accuracy of these surgical procedures. This in turn, will stimulate neurovascular industry over the coming years of 2016 to 2024. This market is highly consolidated and includes the participation of giants such as Stryker, Johnson & Johnson, Terumo, Medtronic, and Penumbra. Reportedly, Stryker has a lion’s share in global neurovascular devices market revenue, primarily owing to the clever business tactics undertaken by the company at regular intervals. The lack of skilled neuro-medical experts and the rising cost of neurovascular devices is likely to pose a restraint to global neurovascular devices industry growth. Key participants, however, are working toward effectively combating these restraints by means of strategic acquisitions and innovative product developments.
Neurovascular devices are principally utilized in end-use sectors such as hospitals, ambulatory surgical units, and clinics. Hospitals are estimated to depict the highest growth rate between 2016-2024, having accounted for over 85% of the overall industry share in 2015. Neurovascular devices market from ambulatory surgical units is expected to grow significantly, especially across the U.S. and Germany, owing to the high prevalence of brain disorders pertaining to the rising obese population in the region.
Speaking of the United States, the country accounted for more than 71.6% of global neurovascular devices market share in 2015 and is projected to grow remarkably over the coming years, essentially driven by the highly developed medical infrastructural facilities, a rapidly rising patient pool, increased healthcare expenditure, and technological innovations in neuroscience. The rise in healthcare spending is also observed to be a major growth driver for APAC neurovascular devices industry, especially across countries such as India, China, and Japan. In fact, Japan is slated to hold more than 47% of Asia Pacific neurovascular devices market by 2014. The rise in per capita income, low cost production facilities, and favorable healthcare insurance will further augment the regional growth.
Rise in GDP may also be a key factor promoting the growth of neurovascular devices industry in developing economies such as Brazil. Latin America, with Brazil at the helm, will observe the highest growth of 5.5% over 2016-2024, driven by the rising prevalence of brain-related disorders and an increase in the number of geriatric patients. Leading companies are concentrating on neurovascular research & development activities and expanding their footprint in the untapped regions of emerging economies to sustain their position in global neurovascular devices market.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/794
Neurovascular devices comprise embolic protection devices, liquid embolic coils, embolic coils, stent retrievers, flow diverters, carotid stents, balloons, neurovascular thrombectomy, intracranial stents, and intrasaccular devices. Flow diverters and stent retrievers are anticipated to exhibit the highest growth rate over 2016-2024. Thrombectomy neurovascular devices market is expected to register a revenue of more than USD 300 million by 2024.
Embolic coils dominated the product landscape of neurovascular devices industry by accounting for a share of more than 30% of the overall revenue in 2015. The increasing usage of these products in coiling and other neurovascular procedures will stimulate the industry growth. Speaking of which, neurovascular devices market from coiling procedures is slated to depict the maximum gain over 2016-2024, with a revenue estimation of more than USD 750 million by 2024. This growth can be attributed to the technological advancements embedded in these devices coupled with the rising number of personal and government funding for novel product development.
Driven by favorable reimbursement plans, neurovascular devices market from stenting procedure is predicted to record the highest CAGR over 2016-2024. Rising adoption of carotid stents and balloon catheters by neurosurgeons for agile treatment procedure will further fuel the industry growth.
Neurovascular devices find applications in stenosis, brain aneurysm, and ischemic strokes. The world is witnessing an exponential rise in the number of patients suffering from aneurysms and strokes. As per reliable sources, more than 4% of the population in America is suffering from aneurysms. Neurovascular devices market from ischemic strokes is estimated to observe the highest growth between 2016-2024. Brain aneurysm, having held a share of more than 70% of overall neurovascular devices industry in 2015, will depict a substantial growth rate over the coming years, due to increased penetration of aneurysms among the age group of 35 to 60, especially across emerging economies.
Strategic mergers & acquisitions are key growth strategies adopted by neurovascular devices market players for expanding their presence across the globe. Such collaborations also help companies concentrate on clinical trials to enable the marketing of cost-effective procedures.
Author Name :Saipriya Iyer
U.S. smart water metering market to record huge gains over 2017-2024, high adoption across the commercial sector to accelerate the regional growth
As the world experiences a tremendous need to conserve natural resources such as water, smart water metering market will gain considerable traction, subject to the rising demand for efficient water consumption. Smart meters help record real-time data and reduce water bills, thereby enabling water conservation. The deployment of smart water meters will augment the rising efforts to save water and prevent its unnecessary wastage, thereby stimulating smart water metering industry. A report by Global Market Insights, Inc., states that smart water metering market, worth more than USD 6 billion in 2016, will register a revenue of more than USD 14 billion by 2024.
Stringent regulations toward the conservation of water and the regulation of the water distribution network will propel smart water metering industry. As per the EC Directive 2000/60/EC, it is mandatory for respective nations to prioritize the prevention of water wastage and water conservation, especially in drought-ridden areas of the region. Technologically, smart water meters can be deployed based on two key technologies – automatic meter reading (AMR) and automatic meter infrastructure (AMI). AMR-based smart water metering market is slated to surpass 150 million units by 2024, primarily driven by the increasing adoption of this technology across myriad application sectors for the last two decades. AMR technology is also deployed in smart electric meters and smart gas meters, thereby stimulating global smart electric meter industry and smart gas metering systems market respectively.
Germany Smart Water Metering Market Size, By Application, 2016 (Million Units)
Smart meters help curb water losses and streamline billing processes. Water utilization data gathered by AMI-based smart meters also help identify problems in water distribution and manage water allocation in an efficient manner, which eventually serve to understand consumer requirements. On these grounds, AMI-based smart water metering market size is slated to exceed 50 million units by 2024, with a CAGR projection of 10% over 2017-2024. While AMI technology is relatively advanced, its excessive cost may restrain the market growth over the next few years. This technology is widely deployed across residential and utility application sectors.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/697
Smart water meters, in general, find massive applications across the commercial, residential, and utility sectors. Smart water metering industry from commercial applications will witness a CAGR of more than 155 over 2017-2024, driven by rising water bills pertaining to the irregular supply of water. End-users of commercial applications have gauged the importance of water and the effects of unregulated resource spending on the application sector, owing to which smart water metering market from commercial applications is likely to witness enormous growth prospects. Commercial applications accounted for more than 35% of the overall smart water metering market in 2016.
Smart meters are widely used across residential applications, subject to the high demand for transparency in water utilization and billing. Smart water metering industry from residential applications will exceed 90 million units by 2024, pertaining to the rising need for efficient consumption tracking and water bill reduction.
AMI-based smart meters are particularly used across the utility sector, for efficient water allocation and management. Stringent regulations regarding water conservation will drive smart water metering market from utility applications, projected to grow at a CAGR of 13% over 2017-2024.
Glendale was the first city in the United States that set a benchmark for better utility management and responding to unexpected natural calamities such as droughts, by means of implementing smart meters to develop a smart grid network. Rising adoption of smart water meters and strict norms pertaining to accurate billing and water conservation will drive U.S. smart water metering industry, set to surpass USD 3 billion by 2024. Government regulations toward the accountability of NRW (non-revenue water) will also augment the regional growth.
UK smart water metering market is forecast to grow at a CAGR of 12% over 2017-2024, subject to the increasing demand for smart metering infrastructure. The government of Japan aims to achieve a 100% roll-out of smart water meters by 2025, which will propel Japan smart water metering industry, worth USD 300 million in 2016.
Companies operating in global smart water metering market are engaged in periodic mergers and acquisitions to consolidate their position. Key participants include Datamatic, Arqiva, Neptune Technology, Siemens AG, Diehl, Arad, Itron, Elster, Badger Meter, Aclara Technologies, Sensus, Xylem, Landis+Gyr, and Kamstrup.
Author Name :Saipriya Iyer
Germany ophthalmic viscosurgical devices market to register substantial gains over 2016-2024, high prevalence of eye disorders to drive the demand
Ophthalmic viscosurgical devices market is expected to carve a remarkable growth path, owing to the surging product requirement for age-related cataract treatment. Reliable statistics state that more than 10 million cataract operations are carried out across the globe. According to Global Market Insights, Inc., “Worldwide ophthalmic viscosurgical devices market will surpass a revenue collection of USD 790 million by 2024 with an annual growth rate of more than 10% over the years ahead.” Increasingly changing dietary habits and a hectic, modern lifestyle has led to a widespread occurrence of diabetes. Diabetic people are vulnerable to ocular disabilities such as blindness and diabetic retinopathy, which in turn, will favor ophthalmic viscosurgical devices industry growth noticeably.
U.S. Ophthalmic Viscosurgical Devices Market Size, By Application, 2012-2024 (USD Million)
Based on the products, ophthalmic viscosurgical devices market is mainly divided into cohesive, dispersive, and combined. Dispersive devices covered more than 47% of the revenue share in 2015 and will exhibit lucrative growth prospects over the coming years of 2016 to 2024. The prominent usage of these devices for cataract surgeries due to their notable rheological characteristics will augment the product demand. Cataract surgery application acquired more than 49% of the market share of the application landscape in 2015 and will record a CAGR of 12.6% over the period of 2016 to 2024. The number of patients affected by cataract are increasing substantially across the globe, which will noticeably boost the demand for ophthalmic viscosurgical devices.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1134
Cohesive ophthalmic viscosurgical devices market is anticipated to cover a market share of about 40% over the coming years of 2016 to 2024, owing to the cohesive nature of the device, which is mainly used in OVD retention for phacoemulsification. Phacoemulsification technology is extensively used for the treatment of cataract.
Vitreoretinal surgery is another attractive application segment of ophthalmic viscosurgical devices market. Vitreoretinal surgery was worth more than USD 53 million in 2015 and will cross a revenue collection of USD 150 million by 2024. The growth can be attributed to the surging need of these devices in diabetic retinopathy, macular degeneration, and diabetic vitreous haemorrhage.
Geographically, Germany ophthalmic viscosurgical devices market will register an annual growth rate of 11.9% over the period of 2016 to 2024, owing to the growing awareness regarding eye-related disorders such as cataracts among the rising geriatric population.
U.S. ophthalmic viscosurgical devices industry was worth more than USD 110 million in 2015 and will exhibit significant growth rate over the years ahead. The growth can be attributed to the growing occurrence of ophthalmic ailments such as diabetic retinopathy, cataract, and glaucoma. In addition, the availability of advanced healthcare facilities and supportive reimbursement policies will augment the industry growth noticeably.
Japan ophthalmic viscosurgical devices market collected a revenue of over USD 12 million in 2015 and will cross a market value of USD 41 million by 2024, primarily driven by the invasively growing geriatric population.
Industry giants will focus on product differentiation, strategic partnerships, and new product launches to sustain their position in the market. Top business competitors occupied more than 50% of the revenue share in 2015. Key participants in ophthalmic viscosurgical devices market are Abbott Medical Optics Inc., Alcon, Bausch & Lomb, Carl-Zeiss, Hyaltech Ltd., CIMA Technology, Inc., Rayner, and Precision Lens.
Author Name :Sunil Hebbalkar
Portable homecare oxygen concentrators market to witness phenomenal gains over the years ahead, APAC slated to record the fastest growth
Homecare oxygen concentrators market is witnessing a significant upsurge, driven by the rising number of chronic obstructive pulmonary disease (COPD) patients across the globe. A considerable increase in the number of cigarette smokers and rising exposure to pollution and dust will increase the prevalence of COPD among people. Moreover, the geriatric population is more susceptible to respiratory diseases such as asthma, pulmonary hypertension, fibrosis and are likely to push the growth of homecare oxygen concentrators industry over the years. According to Global Market Insights, Inc., Homecare Oxygen Concentrators Market is projected to witness a CAGR of 12% over the period of 2016-2023 with a revenue target of USD 1.5 billion by 2023.
Product innovation in this market is likely to gain considerable traction with the growing demand for flow technology. Portable oxygen concentrators, liquid oxygen, compressed gas oxygen cylinders are the three trending homecare oxygen concentrators product segments. Compressed gas oxygen cylinder is estimated to generate a revenue of over USD 57 million by 2023, owing to its availability in varied sizes based on the oxygen level requirements. However, the explosion risks associated with these devices coupled with their heavy weight may impede the device market expansion over the coming years.
Germany Homecare Oxygen Concentrators Market size, by product, 2012-2023 (USD Million)
Combating the disadvantages such as heavyweight and complex designs, portable homecare oxygen concentrators are witnessing an appreciable adoption rate. Portable homecare oxygen concentrators industry held a major share of over 75% of the global product landscape, and is projected to register a CAGR of 10% over the period of 2016-2023. The compact size of this device and light weight are the complementing factors attracting major revenue for this market.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1205
U.S. almost covered 88% of North America’s homecare oxygen concentrators industry share in 2015 and is slated to attain stupendous growth over the years ahead. Increasing incidence of pulmonary diseases, especially across the elderly population is driving the demand for home health care, which in turn is providing ample opportunities to the regional market. Additionally, favorable insurance policies which cover a large portion of device cost is further acting as a catalyst for the growth trajectory path of the homecare oxygen concentrators market.Huge geriatric base, upgraded living standards, and technologically advanced healthcare infrastructure are the key factors behind the rapid expansion of the APAC homecare oxygen concentrators market. China, India, and Japan are expected to be the major revenue pockets of the regional market.
Japan homecare oxygen concentrators industry generated a revenue of USD 52 million in 2015 and is estimated to cross over USD 138 million by 2023. With strategic collaborations and continuous product upgradation, Asia Pacific market is poised to record maximum growth rate in the coming time frame.
Germany dominated the Europe homecare oxygen concentrators market in 2015, accounting for almost 31% of the regional revenue with a market value of USD 54 million. In the coming time frame too, this country is estimated to experience a striking growth curve at a CAGR of 10% over 2016-2023. Sheer consumer demand for upgraded health care services along with a good number of market players’ availability is stimulating the business expansion in this region.
Continuous efforts on improving the product portfolio and mergers & acquisitions are the major strategies adopted by the industry players to sustain their market position. Some of the prominent players of homecare oxygen concentrators market include Teijen, Covidien, Invacare, Precision Medical, and AirSep.
Author Name :Ojaswita Kutepatil
U.S. to lead global protein A resins market landscape over 2016-2024, technological advanced clinical infrastructure to drive the regional growth
The increasing usage of monoclonal antibodies for therapeutic and diagnostic purposes will multiply Protein A resins market revenue in the years ahead. Industry players are focusing on manufacturing copious quantities of biosimilars to reduce the escalating medicine costs, which depicts a positive growth for the industry. Beneficial government norms supporting production of biosimilars will also spur the global demand for the products. As per Global Market Insights, Inc., “Protein A Resins Industry, which accumulated a revenue of USD 440 million in 2015, is slated to surpass USD 900 million by 2024.”
Protein A resins are extensively used in antibody purification and immunoprecipitation processes. Antibody purification application segment is forecast to hit USD 700 million by 2024 and will contribute notably towards protein A resins industry size. Enhanced use of antibodies for diagnosing and treating dreaded diseases will push the revenue.
Immunoprecipitation, which contributed over 20% of protein A resins market share in 2015, is forecast to record a CAGR of 8% over the period of 2016 to 2024. Escalating usage of protein A resin products in purifying specified composites will help the industry to progress rapidly.
Japan Protein A Resin Market size, by matrix type, 2012-2024 (USD Million)
Contract research organizations, biopharmaceutical firms, academic research institutions, and clinical research institutes are the prominent end-use industries that extensively use protein A resins. Protein A resins market size from contract research organizations (CRO) is forecast to surpass USD 130 million by 2024, growing at an annual rate of 8.1% over 2016-2024. Massive outsourcing of protein purification processes by pharmaceutical & biotechnology firms and academic institutes will complement the growth.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1146
Biopharmaceutical firms, which contributed more than 75% of protein A resins industry share in 2015, will hit a revenue margin of over USD 680 million by 2024. Global requirement for monoclonal antibodies for efficient diagnosis will augment the revenue.
Based on the product trends, protein A resins industry is classified into natural protein A resins and recombinant protein A resins. Natural protein A resins market is forecast to grow at a rate of 8% over 2016-2024 and will hit revenue of over USD 580 million by 2024. Highly beneficial product characteristics such as enhanced antibody production, convenient operation, and antibody purification will augment the growth.
Taking into consideration the regional trends, APAC protein A resins market is expected to record a CAGR of 8.5% over the period of 2016-2024. Beneficial legislations, reasonably developed healthcare infrastructure, and the easy availability of experts has prompted many CROs and biopharmaceutical firms to set up their business in the region. Japan protein A resins industry, worth USD 37 million in 2015, is intended to reach USD 78 million by 2024.
U.S. protein A resins industry, which accounted for over 85% of North America protein A resins market revenue in 2015, will witness a remarkable expansion over the coming years. A robust clinical infrastructure coupled with stringent government regulations regarding the usage of protein A resin products will play a vital role in shaping the business across the region.
Mexico protein A resins market is forecast to grow at a rate of 8% over the period of 2016-2024 and will drive the LATAM industry size. Growing use of monoclonal antibodies in clinical research activities is expected to impel the revenue.
Considering the matrix trends, protein A resins industry is segmented into organic polymer, agarose, and glass/silica gel. Agarose-based matrix, which contributed over 80% of protein A resins market size in 2015, is intended to record an annual growth of 8.3% over the period of 2016-2024, driven by ligand binding stability of this particular matrix. Silica gel based matrix is expected to register considerable gains of 8.4% over the coming seven years.
Strategic collaborations and product innovations are a couple of important business strategies adopted by leading companies to increase their return on sales and expand their business. Key industry participants include Danaher Corporation, Purolite Life Sciences, Novasep Holding SAS Company, GE Healthcare, Thermo Fisher Scientific, Bio-Rad Laboratories Incorporation, Sigma-Aldrich Corporation, GenScript Biotech Corporation, Agarose Bead Technologies, Takara Bio Incorporation, Expedeon Limited, and Merck Millipore Corporation.
Author Name :Dhananjay Punekar